Arcturus Therapeutics Ltd Stock Nasdaq
Equities
IL0011280240
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 182M | Sales 2025 * | 229M | Capitalization | 624M |
---|---|---|---|---|---|
Net income 2024 * | -91M | Net income 2025 * | -60M | EV / Sales 2024 * | 1.58 x |
Net cash position 2024 * | 336M | Net cash position 2025 * | - | EV / Sales 2025 * | 2.72 x |
P/E ratio 2024 * |
-6.89
x | P/E ratio 2025 * |
-11.6
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.51% |
Latest transcript on Arcturus Therapeutics Ltd
Managers | Title | Age | Since |
---|---|---|---|
Joseph Payne
CEO | Chief Executive Officer | 52 | 13-02-28 |
Andrew Sassine
DFI | Director of Finance/CFO | 59 | 18-12-31 |
Chief Operating Officer | 45 | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Edward Holmes
BRD | Director/Board Member | 83 | 19-08-31 |
James Barlow
BRD | Director/Board Member | 65 | 18-05-26 |
Peter Farrell
CHM | Chairman | 81 | 18-05-26 |
1st Jan change | Capi. | |
---|---|---|
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |